Great Deal! Get Instant $10 FREE in Account on First Order + 10% Cashback on Every Order Order Now

Subpart A of 45 CFR Part 46: Basic HHS Policy for Protection of Human Subjects Common Rule Departments and Agencies Facts about the Common Rule departments and agencies:  19 agencies (including HHS)...

1 answer below »

Subpart A of 45 CFR Part 46: Basic HHS Policy for Protection of Human Subjects























Common Rule Departments and Agencies
Facts about the Common Rule departments and agencies:
     19 agencies (including HHS) followed the pre-2018 Requirements
o     Of these, 15 departments and agencies were official signatories with the rule codified in their own
Code of Federal Regulations (CFR) sections
o     Four departments and agencies followed the pre-2018 Common Rule because of executive order
or statutory mandate (Department of Homeland Security, Social Security Administration, Office of
the Director of National Intelligence, and Central Intelligence Agency)
     19 agencies (including HHS) follow the revised Common Rule. One department intends to follow the
evised Common Rule
o     There is 1 new signatory to the revised Common Rule (Department of Labor)
o     Two agencies that followed the pre-2018 Common Rule because of executive order or statutory
mandate have become official signatories to the revised Common Rule (Department of Homeland
Security and Social Security Administration)
o     One original signatory (Department of Justice) intends to become an official signatory to the
evised Common Rule
     The Food and Drug Administration (FDA) is an HHS agency that regulates clinical investigations of
products under its jurisdiction, such as drugs, biological products, and medical devices. FDA is not
considered a Common Rule agency because its regulations differ from the Common Rule.
List of Common Rule Departments and Agencies:
DEPT. OR AGENCY
CFR CITATION
(2018 REQUIREMENTS)
1 Department of Homeland Security 6 CFR Part 46
2 Department of Agriculture 7 CFR Part 1c
3 Department of Energy 10 CFR Part 745
4 National Aeronautics and Space Administration 14 CFR Part 1230
5 Department of Commerce 15 CFR Part 27
6 Social Security Administration 20 CFR Part 431
7 Agency for International Development 22 CFR Part 225
8 Department of Housing and U
an Development 24 CFR Part 60
9 Department of Justice 28 CFR Part 46
10 Department of Labor 29 CFR Part 21
11 Department of Defense 32 CFR Part 219
12 Department of Education 34 CFR Part 97
13 Department of Veterans Affairs 38 CFR Part 16
14 Environmental Protection Agency 40 CFR Part 26
15 Department of Health and Human Services 45 CFR Part 46
16 National Science Foundation 45 CFR Part 690
17 Department of Transportation 49 CFR Part 11
18 Office of the Director of National Intelligence Follows CR because of EO 12333, as amended
19 Central Intelligence Agency Follows CR because of EO 12333, as amended
20 Consumer Product Safety Commission 16 CFR Part 1028













DISCLAIMER
This booklet does not contain an official version of the United States Code
    
(USC) or the revised Common Rule regulatory text.
    
The statutory text included in this booklet shows sections of the United States
    
Code (USC), cu
ent as of December 20, 2018, unless otherwise noted.
    
For an official version of the statutory text and for information about the
    
legislative history of theses statutory provisions, please visit the Office of the
    
Law Revision Counsel’s United States Code website, available at:
    
http:
uscode.house.gov
owse.xhtml.
    
***
The regulatory text included in this booklet shows the revised Common Rule,
published in the Federal Register on January 19, XXXXXXXXXXFR 7149), and
further amended by an interim final rule published on January 22, XXXXXXXXXXFR
2885) and a final rule published on June 19, XXXXXXXXXXFR 28497).
There may be slight discrepancies in the regulatory text below (e.g., spacing,
capitalization) compared to the official version of the regulatory text. You can
view an official version of the revised Common Rule regulatory text in the July
19, 2018 edition of the e-Code of Federal Regulations, available at:
https:
gov.ecfr.io/cgi-bin/ECFR.
1
https:
gov.ecfr.io/cgi-bin/ECFR
http:
uscode.house.gov
owse.xhtml





















Statutory Authorities for Subpart A of 45 CFR Part 46
5 U.S.C. 301
§301. Departmental regulations
The head of an Executive department or military department may prescribe regulations for the government of his department, the conduct
of its employees, the distribution and performance of its business, and the custody, use, and preservation of its records, papers, and
property. This section does not authorize withholding information from the public or limiting the availability of records to the public.
(Pub. L. 89–554, Sept. 6, 1966, 80 Stat. 379)
42 U.S.C. 289(a)
§289. Institutional review boards; ethics guidance program
(a) The Secretary shall by regulation require that each entity which applies for a grant, contract, or cooperative agreement under this
chapter for any project or program which involves the conduct of biomedical or behavioral research involving human subjects submit in or
with its application for such grant, contract, or cooperative agreement assurances satisfactory to the Secretary that it has established (in
accordance with regulations which the Secretary shall prescribe) a board (to be known as an "Institutional Review Board") to review
iomedical and behavioral research involving human subjects conducted at or supported by such entity in order to protect the rights of the
human subjects of such research.
(July 1, 1944, ch. 373, title IV, §491, as added Pub. L. 99–158, §2, Nov. 20, 1985, 99 Stat. 873)
42 U.S.C. 300v-1(b) (omitted in the cu
ent version of the U.S.C.)
§300v-1(b). Recommendations to agencies; subsequent administrative requirements
(1) Within 60 days of the date a Federal agency receives a recommendation from the Commission that the agency take any action with
espect to its rules, policies, guidelines, or regulations, the agency shall publish such recommendation in the Federal Register and shall
provide opportunity for interested persons to submit written data, views, and arguments with respect to adoption of the recommendation.
(2) Within the 180-day period beginning on the date of such publication, the agency shall determine whether the action proposed by such
ecommendation is appropriate, and, to the extent that it determines that—
(A) such action is not appropriate, the agency shall, within such time period, provide the Commission with, and publish in the Federal
Register, a notice of such determination (including an adequate statement of the reasons for the determination), or
(B) such action is appropriate, the agency shall undertake such action as expeditiously as feasible and shall notify the
Answered Same Day Mar 05, 2022

Solution

Deblina answered on Mar 06 2022
107 Votes
Codes of Federal Regulation         2
CODES OF FEDERAL REGULATION
Table of Contents
Response to the Questions    3
Question 1    3
Prospect of Direct Benefit    3
Minimal Risk    4
Question 2    5
Parents’ Consent on Fetus    5
References    7
Response to the Questions
Question 1
Prospect of Direct Benefit
The Subpart D of the Code of Federal Regulations guidelines for the additional protections in pediatric research subjects that offer the prospect of direct benefit. This is contemplated because children can be vulnerable to a greater risk in terms of other research and their dissent can be ove
idden. The concept of direct benefit explains how these aspects are different from indirect benefits or other types of benefits. Accordingly, they are three types of benefits that are important in terms of the research context. Those are direct benefit, collateral benefit, and aspirational benefit. Direct benefits are those benefits that arise from the receiving of the intervention that is being studied which is also refe
ed to as the therapeutic benefit (Bhatnagar et al., 2021).
On the other hand, the Collateral benefit is medical or psychological that is gained from participation in a particular event. This is also termed as the inclusion benefit. Direct benefit in clinical research relates to the health of an individual who is participating in the research and they arise effectively from the research investigation that is being studied. The level of certainty that was required for accessing the prospect of a direct benefit can be addressed by a more rigorous standard for confirming the efficacy of the research outcome. During the early phases of trials, it is typically focused on safety rather than efficacy that generally provides fewer data to support the potentiality of the benefits (Wendler et al., 2019).
The potential benefits during the early phase of the research may enhance the therapeutic misconception when the participants fail to make a difference between the research and the clinical care. The more particularly direct benefit is defined as the possibility of realizing the benefits that an individual may have acquired through participation in the research. However, it is significantly asserted that for the prospect of direct benefit to existing a higher and more defined probability of improvement in how the individual feels, functions, or survives must be present (Różyńska, 2020). It is also agreed that whether the prospect of direct benefit is realized from the intervention is determined by the sufficiency of the probability magnitude and the justification of the wrists of intervention in the context of the child's condition and alternative treatment options. It emphasizes that the child...
SOLUTION.PDF

Answer To This Question Is Available To Download

Related Questions & Answers

More Questions »

Submit New Assignment

Copy and Paste Your Assignment Here